Form 4: Allstate Executive Zulfikar Jeevanjee Reports Stock and Option Awards

Sentiment:

SEC Form 4 Filing


Zulfikar Jeevanjee, EVP & CTO AIC of Allstate Corp, reports the acquisition of restricted stock units and stock options.

Summary

  • Zulfikar Jeevanjee, an executive at Allstate Corp, filed a Form 4 disclosing transactions related to the company's securities.
  • On February 24, 2025, Jeevanjee was granted 1,695 Restricted Stock Units (RSUs) under the company's 2019 Equity Incentive Plan.
  • These RSUs will vest in three equal installments on February 24, 2026, February 24, 2027, and February 24, 2028.
  • Jeevanjee also received an option to buy 6,594 shares of Allstate common stock at a price of $188.75.
  • These options also vest in three equal installments on February 24, 2026, February 24, 2027, and February 24, 2028.
  • The filing also includes a Power of Attorney, effective December 11, 2024, authorizing Julie E. Cho, Meghan E. Jauhar, Jillian K. Ludwig and Lori I. Marsh to act on Jeevanjee's behalf in matters related to SEC filings.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, which is generally viewed neutrally to positively as it aligns executive interests with shareholders.

Positives

  • The grant of RSUs and stock options aligns Jeevanjee's interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the executive.

Industry Context

Executive compensation through equity grants is a common practice in publicly traded companies to incentivize performance and align management's interests with shareholders.

Comparison to Industry Standards

  • Stock option and RSU grants are standard components of executive compensation packages among S&P 500 companies.
  • Companies like Progressive and Geico also utilize similar equity-based compensation plans for their executives.
  • The vesting schedules are typical, designed to retain talent and encourage long-term value creation.

Stakeholder Impact

  • The equity grants could potentially dilute existing shareholders' ownership, although the impact is likely minimal.
  • The grants incentivize the executive to improve company performance, which benefits shareholders, employees, and other stakeholders.

Key Dates

DateDescription
2024-12-11Date of Power of Attorney execution
2025-02-24Date of RSU and stock option grant
2026-02-24First vesting date for RSUs and stock options
2027-02-24Second vesting date for RSUs and stock options
2028-02-24Final vesting date for RSUs
2035-02-24Expiration date for stock options
2025-02-26Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.